COVID-19 Updates

Information is available for the campus community on the Return to Learn website. Please get vaccinated and stay up to date with County and State guidelines as well as CDC recommendations.

News Release

Alumni-led Lucira Health earns 1st FDA authorization for at-home COVID test

San Diego, Calif., Nov. 18, 2020 --On Tuesday, the Food and Drug Administration gave emergency use authorization to the first rapid at-home COVID-19 test, developed by Lucira Health. Erik Engelson, a UC San Diego bioengineering and microbiology alumnus, is president and CEO of Lucira Health.

Erik Engelson, president and CEO of Lucira Health, and UC San Diego bioengineering alumnus.

The Lucira COVID-19 All-In-One Test Kit is a molecular (real-time loop mediated amplification reaction) test that uses a simple nasal swab to return results in 30 minutes, at home. Lucira says the test will cost less than $50, and requires a prescription from a health care provider.

The test works by swirling the self-collected sample swab in a vial that is then placed in the test unit. In 30 minutes or less, the results can be read directly from the test unit’s light-up display.

Read more about the test in the New York Times.

Engelson earned his bachelor’s degree in microbiology from UC San Diego, and then a master’s in bioengineering from the Jacobs School of Engineering at UC San Diego. Engelson is a Trustee Emeritus of the UC San Diego Foundation; Initial Chairman of the Board of Trustees of UC San Diego’s Bioengineering Department; a member of the UC San Diego Division of Biological Sciences Dean’s Leadership Council; and an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE).


Media Contacts

Katherine Connor
Jacobs School of Engineering